Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
First-in-class preclinical work demonstrating a novel nanoparticle approach in animal xenograft models; lacks human efficacy data, controlled comparators, and peer-reviewed publication details required for clinical translation.
This is a narrative review that synthesizes mechanistic evidence and emerging therapeutic concepts without reporting primary trial data, clinical outcomes, or comparative effectiveness.